Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality

Patient prognosis and embryo cohort quality seem to be major factors in MZT rate in women undergoing blastocyst transfer. Although technology-based effects cannot be excluded, patient and embryo characteristics play an important role.